{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:00:59Z","timestamp":1794538859906,"version":"4.9.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Gastrointestinal endoscopic interventions have become a routine practice in healthcare institutions. Propofol has been the most preferred general anesthetic agent for gastrointestinal endoscopic interventions. Ciprofol is a novel compound that has been approved by the China Medical Products Administration for sedation during gastrointestinal endoscopic procedures since December 2020. In this analysis, we aimed to systematically compare ciprofol versus propofol during gastroenteroscopy in Chinese patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The search databases included MEDLINE, EMBASE, Google scholar, Web of Science, <jats:ext-link>http:\/\/www.Clinicaltrials.gov<\/jats:ext-link>, and the Cochrane database. Studies which were based on Chinese participants were included in this analysis. The procedural outcomes and adverse drug events were considered as the endpoints. Statistical analysis was carried out by the RevMan software version 5.4. Risk ratios (RR) with 95% confidence intervals (CI) were used to represent results for dichotomous data whereas weighted mean differences (WMD) with 95% CI were used to represent the result for continuous data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twelve studies with a total number of 2055 Chinese participants (enrolled from 2017 to 2023) were included in this analysis whereby 1073 participants were assigned to ciprofol and 982 participants were assigned to propofol. Following the administration of anesthetic agent, the results for the induction time [WMD: 0.33; (95% CI: \u22120.64 to 1.30); <jats:italic>P<\/jats:italic> = 0.50], awake time [WMD: 0.42, (95% CI: 0.03\u20130.81); <jats:italic>P<\/jats:italic> = 0.03], duration of gastroenteroscopy [WMD: 0.22; (95% CI: \u22120.09 to 0.53); <jats:italic>P<\/jats:italic> = 0.16] and recovery time [WMD: 0.48; (95% CI: 0.13\u20130.83); <jats:italic>P<\/jats:italic> = 0.007] were not significantly worse with ciprofol compared to propofol. In addition, ciprofol was associated with a significantly lower risk of injection pain (RR: 0.15, 95% CI: 0.08\u20130.27; <jats:italic>P<\/jats:italic> = 0.00001), respiratory depression (RR: 0.49, 95% CI: 0.36\u20130.74; <jats:italic>P<\/jats:italic> = 0.0003), hypotension (RR: 0.76, 95% CI: 0.64\u20130.90; <jats:italic>P<\/jats:italic> = 0.001) and drowsiness (RR: 0.75, 95% CI: 0.57\u20130.98; <jats:italic>P<\/jats:italic> = 0.04). The risk for nausea and vomiting (RR: 0.95, 95% CI: 0.50\u20131.80; <jats:italic>P<\/jats:italic> = 0.87), bradycardia (RR: 1.03, 95% CI: 0.60\u20131.76; <jats:italic>P<\/jats:italic> = 0.92) and dizziness (RR: 0.93, 95% CI: 0.63\u20131.36; <jats:italic>P<\/jats:italic> = 0.70) were also not increased with ciprofol when compared to propofol in these Chinese patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Through this meta-analysis, it could be concluded that ciprofol was apparently not associated with significantly worse procedural outcomes nor associated with increased adverse drug events compared to propofol during gastroenteroscopy in Chinese patients. However, in view of several limitations in this analysis, this hypothesis should further be confirmed in future studies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1598268","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:25:27Z","timestamp":1750829127000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The novel ciprofol versus propofol during gastroenteroscopy in Chinese patients: a meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaoyan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/a-2205-2613","article-title":"Training in basic gastrointestinal endoscopic procedures: A European society of gastrointestinal endoscopy (ESGE) and European society of gastroenterology and endoscopy nurses and associates (ESGENA) position statement.","volume":"56","author":"Antonelli","year":"2024","journal-title":"Endoscopy."},{"key":"B2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5152\/tjg.2024.23116","article-title":"Efficacy of magnifying endoscopy with narrow-band imaging in the diagnosis of early gastric cancer and gastric intraepithelial neoplasia.","volume":"35","author":"Zhu","year":"2024","journal-title":"Turk J Gastroenterol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/gutjnl-2023-330396","article-title":"British Society of Gastroenterology guidelines on sedation in gastrointestinal endoscopy.","volume":"73","author":"Sidhu","year":"2024","journal-title":"Gut."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e34745","DOI":"10.1097\/MD.0000000000034745","article-title":"Efficacy and safety of alfentanil plus propofol versus propofol only in painless gastrointestinal endoscopy: A meta-analysis.","volume":"102","author":"Yang","year":"2023","journal-title":"Medicine (Baltimore)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13054-023-04559-7","article-title":"Harmful effects of propofol? The Editor\u2019s standpoint.","volume":"27","author":"Vincent","year":"2023","journal-title":"Crit Care."},{"key":"B6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/life13020473","article-title":"Advances in analgosedation and periprocedural care for gastrointestinal endoscopy.","volume":"13","author":"Skiljic","year":"2023","journal-title":"Life (Basel)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2147\/DDDT.S455915","article-title":"Influences of propofol, ciprofol and remimazolam on dreaming during anesthesia for gastrointestinal endoscopy: A randomized double-blind parallel-design trial.","volume":"18","author":"Zhou","year":"2024","journal-title":"Drug Des Devel Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"7443226","DOI":"10.1155\/2023\/7443226","article-title":"Ciprofol: A novel alternative to propofol in clinical intravenous anesthesia?","volume":"2023","author":"Lu","year":"2023","journal-title":"Biomed Res Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ."},{"key":"B10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B11","doi-asserted-by":"publisher","first-page":"9541060","DOI":"10.1155\/2022\/9541060","article-title":"Comparison and clinical value of ciprofol and propofol in intraoperative adverse reactions, operation, resuscitation, and satisfaction of patients under painless gastroenteroscopy anesthesia.","volume":"2022","author":"Chen","year":"2022","journal-title":"Contrast Media Mol Imaging."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2147\/DDDT.S414166","article-title":"The effect of different doses of ciprofol in patients with painless gastrointestinal endoscopy.","volume":"17","author":"Chen","year":"2023","journal-title":"Drug Des Devel Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"111474","DOI":"10.1016\/j.jclinane.2024.111474","article-title":"The efficacy and safety of ciprofol and propofol in patients undergoing colonoscopy: A double-blind, randomized, controlled trial.","volume":"95","author":"Gao","year":"2024","journal-title":"J Clin Anesth."},{"key":"B14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/bcpt.13761","article-title":"Comparison of ciprofol (HSK3486) versus propofol for the induction of deep sedation during gastroscopy and colonoscopy procedures: A multi-centre, non-inferiority, randomized, controlled phase 3 clinical trial.","volume":"131","author":"Li","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e30378","DOI":"10.1016\/j.heliyon.2024.e30378","article-title":"Effect of propofol and ciprofol on the euphoric reaction in patients with painless gastroscopy: A prospective randomized controlled trial.","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e34422","DOI":"10.1097\/MD.0000000000034422","article-title":"Effect of ciprofol on swallowing function in patients undergoing painless gastrointestinal endoscopy.","volume":"102","author":"Liao","year":"2023","journal-title":"Medicine (Baltimore)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e39585","DOI":"10.1097\/MD.0000000000039585","article-title":"Comparative efficacy and safety of ciprofol, propofol, and propofol and etomidate mixture, and ciprofol and etomidate mixture in patients undergoing painless gastroscopy: A randomized, double-blind controlled clinical trial.","volume":"103","author":"Liu","year":"2024","journal-title":"Medicine (Baltimore)."},{"key":"B18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.36502\/2024\/ASJBCCR.6353","article-title":"Comparison of the incidence of postoperative nausea and vomiting between ciprofol and propofol in patients undergoing painless gastroscopy.","volume":"7","author":"Zhao","year":"2024","journal-title":"Asploro J Biomed Clin Case Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"105904","DOI":"10.1016\/j.ejps.2021.105904","article-title":"Efficacy and safety of ciprofol for the sedation\/anesthesia in patients undergoing colonoscopy: Phase IIa and IIb multi-center clinical trials.","volume":"164","author":"Teng","year":"2021","journal-title":"Eur J Pharm Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.dld.2023.09.016","article-title":"Comparison of ciprofol-alfentanil and propofol-alfentanil sedation during bidirectional endoscopy: A prospective, double-blind, randomised, controlled trial.","volume":"56","author":"Zhang","year":"2024","journal-title":"Dig Liver Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13741-025-00529-5","article-title":"Effects of ciprofol on respiratory-related adverse incidence in patients with obesity during painless gastroscopy: A prospective, randomized clinical trial.","volume":"14","author":"Zhang","year":"2025","journal-title":"Perioper Med (Lond)."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","article-title":"Clinical pharmacokinetics and pharmacodynamics of propofol.","volume":"57","author":"Sahinovic","year":"2018","journal-title":"Clin Pharmacokinet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"111317","DOI":"10.1016\/j.jclinane.2023.111317","article-title":"Population pharmacokinetic\/pharmacodynamic modeling and exposure-response analysis of ciprofol in the induction and maintenance of general anesthesia in patients undergoing elective surgery: A prospective dose optimization study.","volume":"92","author":"Liu","year":"2024","journal-title":"J Clin Anesth."},{"key":"B24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12871-025-02907-4","article-title":"Pharmacokinetics and pharmacodynamics of ciprofol after continuous infusion in elderly patients.","volume":"25","author":"Guo","year":"2025","journal-title":"BMC Anesthesiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/EJA.0000000000001799","article-title":"Efficacy and safety of ciprofol vs. propofol for the induction and maintenance of general anaesthesia: A multicentre, single-blind, randomised, parallel-group, phase 3 clinical trial.","volume":"40","author":"Liang","year":"2023","journal-title":"Eur J Anaesthesiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12871-024-02609-3","article-title":"Comparison of the efficacy and safety of ciprofol and propofol in sedating patients in the operating room and outside the operating room: A meta-analysis and systematic review.","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Anesthesiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e071438","DOI":"10.1136\/bmjopen-2022-071438","article-title":"Ciprofol versus propofol for sedation in gastrointestinal endoscopy: Protocol for a systematic review and meta-analysis.","volume":"13","author":"Qin","year":"2023","journal-title":"BMJ Open."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1598268\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:25:27Z","timestamp":1750829127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1598268\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":27,"alternative-id":["10.3389\/fmed.2025.1598268"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1598268","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"1598268"}}